Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

Other Products: In Vivo | Medtech Insight | HBW Insight | Scrip | Generics Bulletin

Sign In

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Existing Subscriber? Sign in to continue reading.

New to Pink Sheet? Start a free trial today!

Email
Share

BIAL-Portela & Cia SA

http://www.bial.com

Already a Biomedtracker subscriber? You have access to the full company record through your subscription

Want to become a subscriber? Subscribers get more company details, updates, company financials and company products.

Questions?

Please contact Sales at: (212) 520-2765 or email [email protected]

Deal Watch: Vanda Buys US, Canadian Rights To J&J’s Ponvory

Bookmark

08 Dec 2023
News

By Joseph Haas

Plus deals involving Bristol Myers Squibb/Avidity, Aexon/NLS, Boehringer Ingelheim/Phenomic AI, AnaptysBio/Centessa and Biodexa/Adhera/Melior.

Deal Watch Business Strategies

Roche’s Novel Ranibizumab Implant Among Myriad New Filings In EU

Bookmark

11 Jun 2021
News

By Neena Brizmohun

The European Medicines Agency has added 13 new drugs to its list of products that are under review for potential pan-EU marketing approval.

Drug Review Europe

See All

Company Information

You must sign in to use this functionality

Authentication.SignIn.HeadSignInHeader

BIAL-Portela & Cia SA

All set! This article has been sent to my@email.address.

All fields are required. For multiple recipients, separate email addresses with a semicolon.

DCD.EmailPopout.Notice